126 related articles for article (PubMed ID: 15597346)
1. Adsorptive Monocyte-granulocytapheresis (M-GCAP) for refractory Crohn's disease.
Kusaka T; Fukunaga K; Ohnishi K; Kosaka T; Tomita T; Yokoyama Y; Sawada K; Fukuda Y; Miwa H; Matsumoto T
J Clin Apher; 2004; 19(4):168-73. PubMed ID: 15597346
[TBL] [Abstract][Full Text] [Related]
2. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study.
Fukuda Y; Matsui T; Suzuki Y; Kanke K; Matsumoto T; Takazoe M; Matsumoto T; Motoya S; Honma T; Sawada K; Yao T; Shimoyama T; Hibi T
J Gastroenterol; 2004 Dec; 39(12):1158-64. PubMed ID: 15622479
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effects of combined enteral nutrition with Tripterygium Wilfordii poly-glycoside in remission induction of active adult Crohn's disease].
Gong JF; Niu LY; Wei XW; Zhu WM; Li N; Li JS
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(16):1213-7. PubMed ID: 19781164
[TBL] [Abstract][Full Text] [Related]
4. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.
Sacco R; Romano A; Mazzoni A; Bertini M; Federici G; Metrangolo S; Parisi G; Nencini C; Giampietro C; Bertoni M; Tumino E; Scatena F; Bresci G
J Crohns Colitis; 2013 Dec; 7(12):e692-7. PubMed ID: 23870727
[TBL] [Abstract][Full Text] [Related]
5. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photochemotherapy for the treatment of refractory Crohn's disease.
Bisaccia E; Palangio M; Gonzalez J
Transfus Apher Sci; 2007 Oct; 37(2):171-4. PubMed ID: 17993292
[TBL] [Abstract][Full Text] [Related]
7. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
Passalacqua S; Ferraro PM; Bresci G; D'Ovidio V; Astegiano M; Principi M; Testa R; D'Incà R; Valpiani D; Armuzzi A; Sablich R; Cavallaro F; Costa F; Di Leo V; Colombo E; Santini A; Aratari A; Lecis P; Saladino V; Riegler G; Marco M; Calella F; Ricci C; Guidi ML; Repaci G; Silla M
J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
[TBL] [Abstract][Full Text] [Related]
8. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
[TBL] [Abstract][Full Text] [Related]
9. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
Thia KT; Sandborn WJ; Lewis JD; Loftus EV; Feagan BG; Steinhart AH; Hanauer SB; Persson T; Sands BE
Am J Gastroenterol; 2008 Dec; 103(12):3123-31. PubMed ID: 18786111
[TBL] [Abstract][Full Text] [Related]
10. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
[TBL] [Abstract][Full Text] [Related]
11. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
Forbes GM; Sturm MJ; Leong RW; Sparrow MP; Segarajasingam D; Cummins AG; Phillips M; Herrmann RP
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):64-71. PubMed ID: 23872668
[TBL] [Abstract][Full Text] [Related]
12. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
Domènech E; Hinojosa J; Esteve-Comas M; Gomollón F; Herrera JM; Bastida G; Obrador A; Ruiz R; Saro C; Gassull MA;
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397
[TBL] [Abstract][Full Text] [Related]
13. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Valentine JF; Fedorak RN; Feagan B; Fredlund P; Schmitt R; Ni P; Humphries TJ
Gut; 2009 Oct; 58(10):1354-62. PubMed ID: 19505878
[TBL] [Abstract][Full Text] [Related]
14. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study.
Omer B; Krebs S; Omer H; Noor TO
Phytomedicine; 2007 Feb; 14(2-3):87-95. PubMed ID: 17240130
[TBL] [Abstract][Full Text] [Related]
15. Low-dose naltrexone therapy improves active Crohn's disease.
Smith JP; Stock H; Bingaman S; Mauger D; Rogosnitzky M; Zagon IS
Am J Gastroenterol; 2007 Apr; 102(4):820-8. PubMed ID: 17222320
[TBL] [Abstract][Full Text] [Related]
16. A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.
Sands BE; Katz S; Wolf DC; Feagan BG; Wang T; Gustofson LM; Wong C; Vandervoort MK; Hanauer S
Gut; 2013 Sep; 62(9):1288-94. PubMed ID: 22760005
[TBL] [Abstract][Full Text] [Related]
17. Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn's disease.
Guo Z; Wu R; Zhu W; Gong J; Zhang W; Li Y; Gu L; Li N; Li J
Nutr Clin Pract; 2013 Aug; 28(4):499-505. PubMed ID: 23851180
[TBL] [Abstract][Full Text] [Related]
18. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
Kanke K; Nakano M; Hiraishi H; Terano A
Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
[TBL] [Abstract][Full Text] [Related]
20. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease.
Fujimori S; Tatsuguchi A; Gudis K; Kishida T; Mitsui K; Ehara A; Kobayashi T; Sekita Y; Seo T; Sakamoto C
J Gastroenterol Hepatol; 2007 Aug; 22(8):1199-204. PubMed ID: 17688660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]